Tilray Brands, Inc.

TSX:TLRY.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$3.23 -1.19%

-$0.08 today

Market cap
$477.35M
Beta
1.88
P/E (TTM)
-0.3
EPS (TTM)
-$16.38
52W Low $0.49High $21.57

Volume 0.86M

Average 0.64M

TLRY.TO Pre-Tax Margin

Income before tax as a percentage of revenue.

Tilray Brands, Inc.TSX: TLRY.TO

Pre-Tax Margin · Q3 FY2026 · quarter ended Feb 2026

Pre-tax margin widens to -11.3%

Pre-tax margin was -11.3% in Q3 FY2026, up 415.2 pp from a year earlier. On a trailing-twelve-month basis it was -169.8%, down 54.6 pp year over year. Over 3 fiscal years it narrowed by 210.2 pp.

Context

  • Pre-tax margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterFeb 2026
-11.3%+7.1 pp QoQ
Last fiscal yearMay 2025
-280.3%-248.8 pp YoY
LTMFeb 2026
-169.8%-54.6 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+415.2 pp——
1 year-248.8 pp——
3 years-210.2 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-280.3%
Year-over-year change
-248.8pp

Pre-Tax Margin vs competitors

How TLRY.TO compares with its peers on the latest reported figures

  • TLRY.TO's LTM Feb 2026 pre-tax margin of -169.8% is the lowest of the 3 companies compared; the peer median is -1.5%.
  • Its year-over-year change of -54.6 pp is the lowest of 3, against a peer median of +1.6 pp.
  • Over three fiscal years its change of -210.2 pp compares with a peer median of +192.1 pp.
TLRY.TO Competitors Peer median
Pre-Tax Margin for TLRY.TO and competitors
Company Period LTM level YoY 3-year change
SNDLSNDL Inc.LTM Mar 2026-1.3% +10.8 pp+51.7 pp
ACBAurora Cannabis Inc.LTM Mar 2026-1.6% -7.6 pp+332.5 pp
TLRY.TOTilray Brands, Inc.LTM Feb 2026-169.8% -54.6 pp-210.2 pp
GLASGlass House Brands Inc—— ——
Peer median (excluding TLRY.TO) -1.5%+1.6 pp+192.1 pp

Competitors are the stored peer set for TLRY.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Revenue513.09M628.37M630.88M788.94M821.31M
Cost of Revenue389.9M511.56M480.16M565.59M580.74M
Gross Profit123.18M116.82M146.96M223.35M240.57M
Gross Margin24.0%18.6%23.3%28.3%29.3%
Research & Development830K1.52M686.09K635K284K
Selling, General & Admin155.69M228.66M232.32M250.72M259.48M
Operating Expenses255.35M215.66M1.04B398.1M2.52B
Depreciation & Amortization67.83M154.59M130.15M126.91M133.49M
EBITDA(246.25M)(246.4M)(1.27B)(72.84M)(2.13B)
EBITDA Margin-48.0%-39.2%-201.8%-9.2%-259.0%
Operating Income(68.55M)(98.85M)(185.85M)(174.75M)(2.28B)
Operating Margin-13.4%-15.7%-29.5%-22.1%-277.9%
Interest Income2.93M11.74M33.03M12.83M11.38M
Interest Expense30.9M39.68M13.59M49.26M41.33M
Other Income / Expenses(212.82M)(341.83M)(1.27B)(74.28M)(19.67M)
Income Before Tax(344.99M)(440.67M)(1.46B)(249.02M)(2.3B)
Pre-Tax Margin-67.2%-70.1%-231.3%-31.6%-280.3%
Income Tax Expense(8.97M)(6.54M)(7.18M)(26.62M)(121.02M)
Net Income(367.42M)(440.67M)(1.44B)(244.98M)(2.19B)
Net Margin-71.6%-70.1%-228.7%-31.1%-266.3%
EPS (Basic)(13.63)(9.95)(23.40)(3.30)(24.10)
EPS (Diluted)(13.63)(9.95)(23.40)(3.30)(24.10)
Weighted Avg Shares26.95M48.12M61.8M74.26M90.83M
Weighted Avg Shares (Diluted)26.95M48.12M61.8M74.26M90.83M

Tilray Brands, Inc.

TSX:TLRY.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.